Targeting Novel Immune Checkpoint Shows Promise in Metastatic CRC

MedPage Today) — Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be effective for patients with metastatic colorectal cancer (CRC) refractory to checkpoint inhibitor immunotherapies…